In 2024, coverage for obesity drugs increased to 44% among employers with 500 or more workers, compared to 41% last year, and 64% among the largest companies, up from 56% the previous year, according to the release
Antigens were diluted in running buffer (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.05% Tween-20, pH 7.4) and injected at seven concentrations (11000 nM, half-log dilution series) in a single-cycle kinetic format
1 Theres no evidence that Wegovy worsens MS
TMA, trimethylamine References 1 AdamsP
As for these GLP-1 drugs, according to the White House, the new prices represent what the drug companies will bill to the government, with Medicaid recipients paying $50 a month as a copay